Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
2025-09-17
This bill, known as the Ensuring Patient Access to Critical Breakthrough Products Act, addresses Ensuring Patient Access to Critical Breakthrough Products Act. It has been introduced and awaits committee review.